MARKET

DARE

DARE

Dare Bioscience Inc
NASDAQ
0.7163
-0.0003
-0.04%
Opening 11:19 09/10 EDT
OPEN
0.7000
PREV CLOSE
0.7166
HIGH
0.7247
LOW
0.7000
VOLUME
32.55K
TURNOVER
--
52 WEEK HIGH
3.780
52 WEEK LOW
0.6900
MARKET CAP
14.09M
P/E (TTM)
-0.9101
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 19h ago
Daré Bioscience Updates Investors with New Presentation
TipRanks · 1d ago
Weekly Report: what happened at DARE last week (0831-0904)?
Weekly Report · 3d ago
Dare Bioscience announces new $908,000 NIH funding award to advance DARE-PTB2
TipRanks · 08/31 13:00
Weekly Report: what happened at DARE last week (0824-0828)?
Weekly Report · 08/31 10:02
Daré Bioscience Announces New NIH Funding Award for Approximately $908,000 to Advance DARE-PTB2 for the Prevention of Preterm Birth
Barchart · 08/31 07:44
Why Now On-Demand Conference Spotlights Nine Emerging Biotech And Healthcare Stories
NASDAQ · 08/29 10:34
Press Release: Daré Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor "Why Now" On-Demand Series
Dow Jones · 08/27 13:01
More
About DARE
Dare Bioscience, Inc. is a biopharmaceutical company. The Company's programs target unmet needs in women's health, primarily in the areas of contraception, sexual health, pelvic pain, fertility, infectious disease, vaginal health and menopause. Its product includes XACIATO (clindamycin phosphate) vaginal gel 2%. XACIATO is a single-dose prescription medication for the treatment of bacterial vaginosis in females 12 years of age and older. Its other product candidates include Ovaprene, Sildenafil Cream, and DARE-HRT1. Ovaprene is an investigational, hormone-free, monthly intravaginal contraceptive. Sildenafil Cream is a novel cream formulation of sildenafil for the treatment of female sexual arousal disorder; and DARE-HRT1 is an intravaginal ring designed to deliver a combination of menopausal hormone therapy, bio-identical 17b-estradiol and progesterone together, continuously over a 28-day period for the treatment of moderate to severe vasomotor symptoms, also known as hot flashes.

Webull offers Dare Bioscience Inc stock information, including NASDAQ: DARE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DARE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DARE stock methods without spending real money on the virtual paper trading platform.